renal collecting duct [4] . In agreement, the level of its 3. Aldosterone synthesis mRNA is low since amplification by polymerase chain reaction was required to evidence its presence in human 3.1. Control of aldosterone synthesis in adrenals heart [6] . Second, MR may also discriminate Aldo from glucocorticoids independently of 11b-HSD2. Indeed, the Glucocorticoids and mineralocorticoids (mainly Aldo) off-rate of Aldo from MR is five times lower than that of are synthesized from cholesterol in the adrenal cortex. The glucocorticoids despite similar affinity constants [7] . Third, first common step of their synthesis is the formation of the transcortin and albumin bind 95% of circulating pregnenolone from cholesterol by the mitochondrial englucocorticoids whereas only 50% of aldosterone is alzyme P450scc (side chain cholesterol cleavage). bumin-bound. Thus, it is likely that selectivity of Aldo
The final step of these synthetic pathways is catalyzed binding to MR in heart is achieved by several mechanisms by two closely related cytochrome P-450 enzymes that that remain partly to be established [8] .
display differences in their enzymatic activity, regulation and tissular distribution. The P-450 11b-hydroxylase (11b-OHase) is encoded by the CYP11B1 gene and synthesizes 2.3. MR mechanism of action corticosterone from deoxyhydrocortisone (DOC) in the zona fasciculata-reticularis, whereas the P-450 aldosteroneUnliganded MR is associated with a complex of synthase (Aldo-synthase) is encoded by the CYP11B2 gene chaperone proteins, including the heat shock protein HSP and catalyzes synthesis of Aldo from DOC in the zona 90 and the immunophilin HSP 56, which maintain the glomerulosa. Recent studies show that Aldo-synthase receptor as inactive. This chaperone protein-associated MR expression and activity is controlled by numerous factors, displays high affinity for corticosteroids. Binding of steroid the main ones being Ang II, potassium and more weakly hormone induces dissociation of chaperone proteins and adrenocorticotropic hormone (ACTH) and sodium. exposition of nuclear localization signals in MR. In the Noticeably, Aldo-synthase and 11b-OHase are mitochonabsence of hormone, MR is present in both cytoplasm and drial enzymes and thus are highly sensitive to tissue nucleus whereas in the presence of Aldo, activated MR oxygen concentration. A large amount of experimental rapidly accumulates in dynamic clusters in the cell nucleus work has been devoted to elucidation of the control [9] . In agreement with the high degree of homology of mechanisms of Aldo synthesis in the adrenal gland. These their DNA binding site, MR and GR bind to common mechanisms have been studied mainly in human adrenonuclear glucocorticoid response elements (GRE) [10] . cortical cultured cells [12] and are summarized in Fig. 1 . Regulation of transcription is also dependent on interaction with the transcription initiation complex and on diverse 3.2. Aldosterone synthesis in heart intracellular signaling pathways. In addition, increasing evidence indicates the existence of co-activators and coBesides the well-known and quantitatively predominant repressors acting as bridging factors between activated adrenal synthesis of Aldo, extra-adrenal sites of production receptors and transcription initiation complex. MR is thus have been detected in nonepithelial tissues, namely in able to bind to specific DNA sequences and to regulate the blood vessels [13, 14] and in brain. Previously, a 3b-expression of Aldo-responsive genes, like Na1 /K1 AThydroxysteroid dehydrogenase activity (this enzyme cataPase in a human renal cell line [10] . In heart however, lyzes pregnenolone conversion to progesterone in the Aldo Aldo target genes are not fully identified. biosynthesis pathway) had been evidenced in cardiac tissue supporting the hypothesis of a cardiac site of synthesis. The demonstration that the whole pathway of Aldo bio-2.4. Membrane receptors synthesis is present in cardiac muscle, and that it is functional, has been done recently [2] . Quantitative RTSeveral rapid effects of Aldo have been described. For PCR analysis gives evidence of Aldo-synthase and 11b-example, Aldo induces, in only 3 min an increase of OHase gene expression in atria and ventricles of the young sodium inward current and of intracellular calcium connormal rat. Cardiac levels of 11b-OHase mRNA are sevencentration in cultured vascular smooth muscle cells [11] .
fold higher than those of Aldo-synthase mRNA, this ratio These effects do not involve protein synthesis, they are being similar in adrenals. Aldo and corticosterone prohighly specific of mineralocorticoids and are not prevented duction have been measured in the isolated rat heart (to by MR antagonists (for example spironolactone). These avoid contamination by plasma steroids) using celite non-genomic mechanisms would be mediated by to date column chromatography coupled to radioimmunoassay. uncharacterized receptors. As described below, rapid Aldo Aldo is detected in heart homogenate under baseline effects are also observed in cardiac isolated cells, which conditions and its level is markedly increased by Ang II suggests that this type of receptor may be present in the and ACTH whereas that of the precursor DOC is deheart.
creased. Additional experiments aimed to study the chronic Fig. 1 . Main pathways of aldosterone synthesis and the control of Aldo-synthase gene expression in human adrenal cortex. As discussed in the Section 3.1, it is likely that this scheme is also valid in heart. Ang II binding on Ang II type I subtype receptor (AT1-R) increases intracellular calcium concentration 21 21 21 (Ca ) . Similarly, extracellular potassium, by decreasing the membrane potential, activates the voltage-sensitive Ca channel and increases (Ca ) .
Ca -calmodulin-dependent phosphorylation of cAMP response element binding protein (CREB) allows its binding to the cAMP response element (CRE) localized in the CYP11B2 59 flanking region and thereby activates Aldo-synthase gene transcription. ACTH induces CREB phosphorylation and Aldo-synthase gene transcription via the adenyl cyclase. The proximal CRE is not sufficient to support CYP11B2 expression and other sequences are required such as the orphan nuclear receptors steroidogenic factor 1 (SF-1) and chicken ovalbumin upstream promoter transcription factor (COUP-TF) [12) ] Abbreviations: Em: membrane potential; PLC. phospholipase C; PKC: protein kinase C; PKA: protein kinase A; PIP: phosphatidyl inositol diphosphate; IP3: inositol triphosphate; CaMK: calmodulin kinase. regulation of this cardiac steroidogenic system have shown sodium intake are chronically increased [15] . The role of that it behaves in a very similar way to that of the adrenal sodium in the pathogenesis of fibrosis is crucial but still gland. The Aldo synthesis pathway is sensitive to low unresolved. To confirm the specific effect of the hormone, sodium / high potassium diet and to Ang II, whereas the it has been shown that inhibition of Aldo binding to MR corticosterone synthesis pathway responds positively to by a low dose of spironolactone prevents only fibrosis but Ang II and ACTH. Thus, it is likely that Aldo synthesis in not the associated hypertension and left ventricle hyheart is controlled by pathways similar to those described pertrophy, whereas a high dose prevents all secondary in adreno-cortical cells, as depicted in Fig. 1 .
effects of the treatment [16] . Whereas hypertrophy and atrial natriuretic peptide mRNA increase are restricted to the left ventricle, fibrosis appears in both ventricles 4. Effects of aldosterone in heart [15, 17, 18] supporting the contention that this Aldo-induced cardiac response is independent of hemodynamic factors.
Cardiac fibrosis
One characteristic feature of this experimental model of hypertension is the long interval of time observed between One of the best documented effects of Aldo on the heart the increase of plasma Aldo (obtained by osmotic is the induction of an important fibrosis, with detrimental minipumps) and the modifications of cardiac structure [19] . consequence for cardiac pump. Karl Weber's group has Indeed, type I and III procollagen increase in both ventrifound that fibrosis appears in rat heart only if Aldo and cles at 2 weeks only, whereas progressive cardiac fibrosis is found at 1 month. At 2 months total given that it is overexpressed in the endothelium of MatrixMetalloProtease-2 activity is increased and localized coronary arteries and endocardium of DOCA-salt treated by in-situ zymography within the media of coronary rats [26] and the endothelin antagonist bosentan decreases arteries, suggesting a role in vascular remodeling [20] .
cardiac fibrosis in the same model [27] . Fig. 2 of AT1 receptors is increased in rats treated for one month Na / K co-transporter activity, and thereby enhances
with Aldo-salt [21, 22] this increase being prevented by inward Na flux and Na / K ATPase activity [29] . In 2 both spironolactone and losartan [22] . The growth promotcultured neo-natal rat myocytes Aldo raises the Cl / 22 ing effect of Ang II has been well described, and it may HCO exchanger activity at 6 days of culture and the
thus participate in the stimulation of myofibroblast prolifNa / H antiport activity at 9 days [30] . eration observed at sites of fibrosis in Aldo-salt or Ang II treated animals [23] . Ang II-induced intracellular calcium 4.3. Rapid (non-genomic) effects increase may also be involved in this process, since the calcium channel blocker mibefradil prevents Aldo-or Ang Rapid effects of Aldo have been evidenced in several II-induced cardiac fibrosis [23] . Increased cardiac bradycell types [11] including cardiac myocytes. Aldo decreases kinin receptor binding is seen in Aldo-salt excess [24] and protein kinase C activity in isolated cardiomyocytes, but blockade of bradykinin B2-receptors prevents the Ang not in fibroblasts, from neonate rat [31] . These rapid II-induced cardiac fibrosis [25] . The postulated pathway of effects (2-10 min), which are not fully inhibited by bradykinin action is also via stimulation of myofibroblast spironolactone, are presumably mediated by a yet unproliferation, possibly mediated by prostaglandin release known membrane receptor and do not involve protein [23] . The intervention of other fibrogenic hormones like synthesis. They may have pathophysiological conseendothelin-1 in Aldo-salt cardiac fibrosis is also likely, quences since a recent study from Wehling's laboratory performed in patients during cardiac catheterization de-6.1. Physiological significance scribes rapid changes of systemic vascular resistance and cardiac output 10 min after Aldo infusion [11] .
To date, direct evidence for the biological significance of the cardiac steroidogenic system is still lacking. However, the discovery of a local steroidogenic system which 4.4. Polymorphisms of aldo-synthase responds both short and long term to physiological stimuli suggests a paracrine or autocrine action for these cardiacSince Aldo has effects on the heart, genetic variations in generated steroids. Measures of Aldo concentration in Aldo synthesis could influence cardiac structure and myocardium furnish an interesting result. Indeed, a value function. A diallelic polymorphism (-344C / T) has been of about 16 nM is found, i.e. 17-fold higher than the mean identified in the promoter region of the human CYP11B2 plasma value [2] . Possible explanations for this are slower gene. In multiple regression analyses, the CYP11B2 Aldo degradation in heart than in plasma, intracellular phenotype was strongly associated with increased left segregation or local delivery into extracellular space ventricular size [32] and modestly with essential hyperteninstead of release into the blood stream. Anyway, this sion [33] . In another study, this polymorphism was associrelatively high Aldo concentration in heart again supports a ated with elevated plasma Aldo and arterial stiffness in putative physiological role. Such a role is yet not known. patients with essential hypertension [34] .
As suggested by previously mentioned studies, cardiac Aldo may be involved in the control of ionic movements [28, 29] . Ang II and Aldo may have interactions in myocardium, as already mentioned since Ang II enhances cardiac
Function(s) of cardiac aldosterone
Aldo synthesis. On the other hand, Aldo increases AT-1 receptor mRNA and density [21, 22] and potentiates Ang 5.1. Characterization of the cardiac steroidogenic system II-stimulated hypertrophy [13] . These actions may thus sensitize cardiac responses to circulating or locally proFuture investigations aimed to characterize this system duced Ang II. Finally, cardiac Aldo may also be involved have to address two crucial points: First, the presence and in cardiac remodeling [15] [16] [17] [18] or in generation of ventricufunctional integrity of the whole catalytic cascade leading lar arrythmias through the control of norepinephrine uptake to the formation of Aldo must be demonstrated under [35] . In this respect, future studies of cardiac Aldo physiologic conditions. In this view, unpublished results synthesis in pathological situations should provide fruitful from our laboratory evidenced the expression of the information. P450scc gene (P450scc catalyzes production of pregnenolone from cholesterol) within cardiac tissue suggesting that the whole pathway of Aldo synthesis is present 7. Conclusion in the heart. Second, the site where the steroidogenic system is located in the heart remains to be defined; both One of the major recent advances in cardiac endocrinolthe coronary vascular cells and the cardiac myocytes must ogy is the discovery of tissular hormonal systems, i.e. the be considered. Vascular endothelial and smooth muscle presence in a cell or a group of cells of all the biochemical cells have been shown to produce Aldo [13, 14] . Since elements necessary for synthesis of a hormone and its cardiac Aldo-synthase mRNA level is low, detection of its specific receptors. These local systems open the possibility expression in the whole heart is technically delicate.
for local autocrine or paracrine actions. A series of However, in preliminary experiments using RT-PCR, we arguments discussed above underline the potential for a detected both Aldo-synthase and 11b-hydroxylase gene physiological role, independently from plasma hormones, expression in isolated neonatal cultured rat myocytes. The of this newly discovered Aldo-generating pathway in determination of the subcellular localization of various cardiac function. In conclusion, the potential biological components of the cardiac steroidogenic system may allow significance of this system represents an exciting new area insights into the functional integration of the system in of research. cardiac physiology. Indeed, if the site of synthesis of a cardiac hormone is close to its site of action (and a comparative study of the localization of biosynthesis enzymes and of receptors would allow this question to be Acknowledgements answered), the response of such a local system is necessarily very short. One may thus think that an hormonal This study was supported by grants from INSERM and system with rapid adaptation is able to modulate in the CNRS. JS Silvestre is the recipient of a fellowship from short term the properties of a group of cells, thus ensuring the Ministere de la Recherche et de l'Enseignement a local fine-tuning relative to the broad influence of Superieur. The authors wish to thank Dr Bernard circulating hormones.
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